Stereotaxis Technology to be Featured at Heart Rhythm Society’s HRX 2025

About this update from Stereotaxis, Inc.

[{"type":"image","alt":"Stereotaxis, Inc.","displaySize":"","headline":null,"caption":"Stereotaxis, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":102,"url":"https://media.zenfs.com/en/globenewswire.com/7fe59cbbf6bc2c2a861b379e08e5c6ad"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/9SBwn9GekjRHtp_pM0a4QA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE0MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/7fe59cbbf6bc2c2a861b379e08e5c6ad","width":300,"height":102}},"lazy":false},{"type":"text","content":"ST. LOUIS, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its technology will be featured during the upcoming HRX digital health conference taking place September 4-6, 2025, in Atlanta, Georgia. HRX, an initiative pioneered by the Heart Rhythm Society, is focused on exploring digital technologies that advance the frontiers of cardiovascular medicine.","length":480,"tagName":"p"},{"type":"text","content":"Stereotaxis CEO, David Fischel, will participate in a roundtable discussion on September 5th at 3:45 PM EDT. Later that day, at 4:45 PM EDT, a distinguished panel of electrophysiologists, including Dr. Daniel Cooper, Prof. Sabine Ernst, Dr. Devi Nair, and Dr. Peter Weiss, will lead a session titled “Cutting-Edge Ablation Techniques That Challenge Traditional Methods and Improve Patient Outcomes”. The session explores the role of robotics, augmented and virtual reality, AI, and automation in improving care for heart rhythm patients.","length":537,"tagName":"p"},{"type":"text","content":"“We appreciate the opportunity to join the HRX community as we jointly define a more advanced, digital and robotic future for the electrophysiology field,” said David Fischel.","length":175,"tagName":"p"},{"type":"text","content":"About StereotaxisStereotaxis (NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, con...

More updates from Stereotaxis, Inc.